Maze Therapeutics, Inc. (MAZE) — Dilution Risk Analysis
Current Snapshot
Maze Therapeutics, Inc. (MAZE) has a DilutionWatch score of 35/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 35/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: 424B5 1, 8-K 1, 4 7, 3 1.
| Form | Filed | Accession |
|---|---|---|
| 424B5 | 2026-04-22 | 0001193125-26-170687 |
| 8-K | 2026-04-22 | 0001193125-26-170701 |
| 4 | 2026-04-02 | 0002050422-26-000012 |
| 4 | 2026-04-02 | 0002050172-26-000019 |
| 3 | 2026-03-31 | 0001742485-26-000002 |
| 4 | 2026-03-31 | 0001742485-26-000003 |
| 4 | 2026-03-03 | 0001676170-26-000002 |
| 4 | 2026-03-03 | 0002050422-26-000010 |
| 4 | 2026-03-03 | 0002050172-26-000013 |
| 4 | 2026-03-03 | 0002050167-26-000005 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $200,000,000 | Source |
| Cash runway | 44 months | Source |
| Three-year share count growth | 29.23% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 35/10) Source
- Cash Runway
- 44 months Source
- ATM Offering Capacity Remaining
- $200,000,000 Source
- Share Count Growth (3-Year)
- 29.23% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.